Mc. Mauri et al., NEUROBIOLOGICAL AND PSYCHOPHARMACOLOGICAL BASIS IN THE THERAPY OF BULIMIA AND ANOREXIA, Progress in neuro-psychopharmacology & biological psychiatry, 20(2), 1996, pp. 207-240
1. Eating disorders can be found in several psychiatric pathologies: s
chizophrenia, delusional disorder (somatic type), bipolar disorders, m
ajor depressive disorder, borderline personality disorder, generalized
anxiety disorder, body dysmorphic disorder, somatization disorder and
conversion disorder. 2. Although their clinical features have been de
fined, relatively little is known about the role of neurobiological pa
tterns in the pathogenesis of these disorders. Several CNS neurotransm
itters and neuromodulators are involved in the regulation of eating be
havior in animals and have been implicated in symptoms such as depress
ion and anxiety often observed in patients with eating disorders. The
authors will review some studies on NA, DA, 5-HT, beta-endorphines, CR
H, VP, OT, CCK, NPY and PYY envolved in eating disorders. Furthermore,
we will highlight some of the studies on drug therapy of eating disor
ders taking into account the effects of these agents on neurotransmitt
ers and neuromodulators.3. Antidepressant drugs have long been used fo
r anorexia nervosa and bulimia, these disorders been claimed to be aff
ective equivalent. Antidepressant agents seem to be effective in reduc
ing the frequency of binge-eating episodes, purging behavior and depre
ssive symptomatology. It is notable that antidepressant agents have be
en proved to be effective in patients with chronic bulimic symptoms, e
ven in cases persisting for many years and in patients who had repeate
dly failed courses of alternative therapeutic approaches. In ail of th
e positive studies, antidepressant agents appeared effective even in b
ulimic subjects who did not display concomitant depression. 4. Few con
trolled studies on use of medications for anorexia nervosa have been p
ublished. Central serotonergic receptor-blocking compounds such as cyp
roheptadine cause marked increase in appetite and body weigh. Zinc sup
plementation or cisapride could be a therapeutic option in addition to
psychological and other approaches in anorexia nervosa. 5. There is n
o therapy as yet which is fully effective in alimentary disorders. Psy
chotropic drugs give some relief from symptoms, but they cannot cure t
he disorders. An integrated approach, either pharmacological or psycho
logical, is still recommendable.